-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Methoxyamine Hydrochloride in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Methoxyamine Hydrochloride in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Methoxyamine Hydrochloride in Solid Tumor Drug Details: TRC-102 (methoxyamine hydrochloride)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Methoxyamine Hydrochloride in Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Methoxyamine Hydrochloride in Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Methoxyamine Hydrochloride in Ovarian Cancer Drug Details: TRC-102 (methoxyamine hydrochloride)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Methoxyamine Hydrochloride in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Methoxyamine Hydrochloride in Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Methoxyamine Hydrochloride in Colorectal Cancer Drug Details: TRC-102 (methoxyamine hydrochloride)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Methoxyamine Hydrochloride in Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Methoxyamine Hydrochloride in Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Methoxyamine Hydrochloride in Lymphoma Drug Details: TRC-102 (methoxyamine hydrochloride) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Envafolimab in Pleomorphic Liposarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Envafolimab in Pleomorphic Liposarcoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Envafolimab in Pleomorphic Liposarcoma Drug Details: Envafolimab (Enweida) is a recombinant...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Envafolimab in Fibrosarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Envafolimab in Fibrosarcoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Envafolimab in Fibrosarcoma Drug Details: Envafolimab (Enweida) is a recombinant humanized single...
-
Product Insights
NewNet Present Value Model: MeiraGTx Holdings Plc’s AAV-AQP1
Empower your strategies with our Net Present Value Model: MeiraGTx Holdings Plc's AAV-AQP1 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewNet Present Value Model: TRACON Pharmaceuticals Inc’s Methoxyamine Hydrochloride
Empower your strategies with our Net Present Value Model: TRACON Pharmaceuticals Inc's Methoxyamine Hydrochloride report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Innovation Ranking
Innovation Ranking – TRACON Pharmaceuticals Inc
TRACON Pharmaceuticals Inc (TRACON) is a biopharmaceutical company. It develops and commercializes targeted therapies for cancer, age-related macular degeneration and fibrotic diseases. The company offers pipeline products such as TRC105, TRC102, TJ004309, TRC253, TRC694, and TRC205. Its lead product TRC105, is an anti-endoglin antibody that is being developed for the treatment of multiple solid tumor types in combination with VEGF inhibitors. TRC102 is a small molecule that is in clinical development for the treatment of lung cancer and glioblastoma. In...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Envafolimab in Soft Tissue Sarcoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Envafolimab in Soft Tissue Sarcoma Drug Details: Envafolimab (Enweida) is a recombinant humanized single domain...